These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 25043296

  • 1. Knockdown of PTHR1 in osteosarcoma cells decreases invasion and growth and increases tumor differentiation in vivo.
    Ho PW, Goradia A, Russell MR, Chalk AM, Milley KM, Baker EK, Danks JA, Slavin JL, Walia M, Crimeen-Irwin B, Dickins RA, Martin TJ, Walkley CR.
    Oncogene; 2015 May 28; 34(22):2922-33. PubMed ID: 25043296
    [Abstract] [Full Text] [Related]

  • 2. PTHR1 May Be Involved in Progression of Osteosarcoma by Regulating miR-124-3p-AR-Tgfb1i1, miR-27a-3p-PPARG-Abca1, and miR-103/590-3p-AXIN2 Axes.
    Li S, Wu X, Pei Y, Wang W, Zheng K, Qiu E, Zhang X.
    DNA Cell Biol; 2019 Nov 28; 38(11):1323-1337. PubMed ID: 31536386
    [Abstract] [Full Text] [Related]

  • 3. Over-expression of parathyroid hormone Type 1 receptor confers an aggressive phenotype in osteosarcoma.
    Yang R, Hoang BH, Kubo T, Kawano H, Chou A, Sowers R, Huvos AG, Meyers PA, Healey JH, Gorlick R.
    Int J Cancer; 2007 Sep 01; 121(5):943-54. PubMed ID: 17410535
    [Abstract] [Full Text] [Related]

  • 4. Convallatoxin suppresses osteosarcoma cell proliferation, migration, invasion, and enhances osteogenic differentiation by downregulating parathyroid hormone receptor 1 (PTHR1) expression and inactivating Wnt/β-catenin pathway.
    Liu X, Geng Z, Ding X, Lou Y, Zhang X.
    Bioengineered; 2022 May 01; 13(5):13280-13292. PubMed ID: 35635031
    [Abstract] [Full Text] [Related]

  • 5. Transcriptomic analyses reveal the underlying pro-malignant functions of PTHR1 for osteosarcoma via activation of Wnt and angiogenesis pathways.
    Li S, Dong Y, Wang K, Wang Z, Zhang X.
    J Orthop Surg Res; 2017 Nov 09; 12(1):168. PubMed ID: 29121993
    [Abstract] [Full Text] [Related]

  • 6. Climbing exercise enhances osteoblast differentiation and inhibits adipogenic differentiation with high expression of PTH/PTHrP receptor in bone marrow cells.
    Menuki K, Mori T, Sakai A, Sakuma M, Okimoto N, Shimizu Y, Kunugita N, Nakamura T.
    Bone; 2008 Sep 09; 43(3):613-20. PubMed ID: 18567552
    [Abstract] [Full Text] [Related]

  • 7. Knockdown of pyruvate kinase type M2 suppresses tumor survival and invasion in osteosarcoma cells both in vitro and in vivo.
    Yuan Q, Yu H, Chen J, Song X, Sun L.
    Exp Cell Res; 2018 Jan 01; 362(1):209-216. PubMed ID: 29155364
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Activation of PTHrP-cAMP-CREB1 signaling following p53 loss is essential for osteosarcoma initiation and maintenance.
    Walia MK, Ho PM, Taylor S, Ng AJ, Gupte A, Chalk AM, Zannettino AC, Martin TJ, Walkley CR.
    Elife; 2016 Apr 12; 5():. PubMed ID: 27070462
    [Abstract] [Full Text] [Related]

  • 11. Integrated network analysis to explore the key genes regulated by parathyroid hormone receptor 1 in osteosarcoma.
    Guan D, Tian H.
    World J Surg Oncol; 2017 Sep 21; 15(1):177. PubMed ID: 28934958
    [Abstract] [Full Text] [Related]

  • 12. Knockdown of galectin-1 suppresses the growth and invasion of osteosarcoma cells through inhibition of the MAPK/ERK pathway.
    Miao JH, Wang SQ, Zhang MH, Yu FB, Zhang L, Yu ZX, Kuang Y.
    Oncol Rep; 2014 Oct 21; 32(4):1497-504. PubMed ID: 25069486
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Neuropilin-2 expression is inhibited by secreted Wnt antagonists and its down-regulation is associated with reduced tumor growth and metastasis in osteosarcoma.
    Ji T, Guo Y, Kim K, McQueen P, Ghaffar S, Christ A, Lin C, Eskander R, Zi X, Hoang BH.
    Mol Cancer; 2015 Apr 17; 14():86. PubMed ID: 25890345
    [Abstract] [Full Text] [Related]

  • 20. Bone-related growth factors and zoledronic acid regulate the PTHrP/PTH.1 receptor bioregulation systems in MG-63 human osteosarcoma cells.
    Tenta R, Sourla A, Lembessis P, Koutsilieris M.
    Anticancer Res; 2006 Apr 17; 26(1A):283-91. PubMed ID: 16475708
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.